Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04755335 · ClinicalTrials.gov registry record
Ultrasonic Perfusion Estimation in Calf Muscle
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 87
- Enrollment target
NCT04755335: Completed study, sponsored by Mayo Clinic.
NCT04755335 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04755335 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the potential of ultrasound perfusion imaging technique for assessing the progression of peripheral arterial disease (PAD) and monitoring its response to therapy by measuring changes in microvessel alterations and perfusion variations.
Interventions
- DIAGNOSTIC_TEST Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2020-02-28 |
| Est. Completion | 2023-05-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04755335
The ClinicalTrials.gov registry entry for NCT04755335 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound is the first listed.
NCT04755335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04755335 about?
NCT04755335 is a clinical study titled "Ultrasonic Perfusion Estimation in Calf Muscle". The purpose of this study is to evaluate the potential of ultrasound perfusion imaging technique for assessing the progression of peripheral arterial disease (PAD) and monitoring its response to therapy by measuring changes in microvessel alterations and perfusion variations.
What is the current status of trial NCT04755335?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2020-02-28. Estimated completion is 2023-05-29.
What interventions are being tested in trial NCT04755335?
The interventions under investigation include: Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04755335?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.